Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Author:
Funder
Suomen Lääketieteen Säätiö
Sosiaali- ja Terveysministeriö
University of Eastern Finland (UEF) including Kuopio University Hospital
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Link
https://link.springer.com/content/pdf/10.1007/s40265-021-01556-4.pdf
Reference104 articles.
1. Moreno-Küstner B, Martín C, Pastor L. Prevalence of psychotic disorders and its association with methodological issues: a systematic review and meta-analyses. PLoS ONE. 2018;13: e0195687. https://doi.org/10.1371/journal.pone.0195687.
2. Owen MJ, O’Donovan MC. Schizophrenia and the neurodevelopmental continuum: evidence from genomics. World Psychiatry. 2017;16:227–35.
3. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187–92.
4. Smeland OB, Frei O, Dale AM, Andreassen OA. The polygenic architecture of schizophrenia: rethinking pathogenesis and nosology. Nat Rev Neurol. 2020;16:366–79.
5. Ripke S, Neale BM, Corvin A, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comments on “The effect on relapse rate and psychiatric symptomatology: Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. A pragmatic randomized open-label trial (SwAP trial)”;Schizophrenia Research;2024-02
2. Exploration of Positive and Negative Schizophrenia Symptom Heterogeneity and Establishment of Symptom-Related miRNA-mRNA Regulatory Network: Based on Transcriptome Sequencing Data;Molecular Neurobiology;2024-01-24
3. Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia;Neurology and Therapy;2024-01-20
4. Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study;Neuropsychopharmacology;2024-01-06
5. Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians’ perspectives;Schizophrenia;2023-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3